How are the vasculitides classified?

Primarily by the calibre of the vessels predominantly affected — large, medium, and small — under the 2012 Revised Chapel Hill Consensus Conference nomenclature, with several small-vessel forms further defined by association with ANCA.

What does 'large vessel disease' mean in this area?

It refers chiefly to granulomatous arteritis of the aorta and its major branches, as in giant cell arteritis and Takayasu arteritis, where inflammation can cause stenosis, occlusion, or aneurysm of large arteries.

Vasculitis and Large Vessel Disease

Vasculitis is inflammation of blood vessel walls, a heterogeneous group of disorders that share the capacity to damage vessels and the tissues they supply. This area organises the vasculitides primarily by the calibre of the vessels predominantly affected — large, medium, and small — a framework formalised by the international Chapel Hill Consensus Conference and used in routine rheumatology classification and teaching.

Znajdź temat z PaperMindWkrótceFind papers & topics

Tools & resources

Pobierz slajdy

Learn & explore

WideoWkrótce

Definition

Vasculitis denotes inflammation of blood vessels; the vasculitides are classified chiefly by the dominant vessel calibre affected (large, medium, small) and, for several small-vessel forms, by association with ANCA, following the 2012 Revised Chapel Hill Consensus Conference nomenclature.

Scope

The area orients the reader to how vasculitides are named and grouped, the vessel-size axis that anchors classification, the role of antineutrophil cytoplasmic antibodies (ANCA) in defining a major subset, and the general logic of remission-induction and maintenance therapy. It links to topic entries on large, medium, and small vessel vasculitis, ANCA-based classification, and treatment phases. It is a reference overview, not clinical guidance.

Sub-topics

Core questions

Which vessel calibre is predominantly involved, and how does that shape the clinical picture?
Is the process a primary vasculitis or secondary to infection, malignancy, drugs, or another systemic disease?
When does an ANCA association define the entity, and what does ANCA specificity (PR3 versus MPO) add?
How do classification criteria differ from diagnostic reasoning at the bedside?

Key concepts

Vessel-size classification (large, medium, small)
Chapel Hill Consensus nomenclature
ANCA-associated vasculitis
Primary versus secondary vasculitis
Granulomatous versus non-granulomatous inflammation
Remission induction and maintenance
Classification criteria versus diagnosis

Mechanisms

Across the group, vessel-wall inflammation can cause stenosis, occlusion, aneurysm, or rupture, producing ischaemia or haemorrhage in the supplied territory. The dominant mechanism varies by category: large vessel vasculitis is characterised by granulomatous arteritis of the aorta and its major branches; small vessel vasculitis includes immune-complex-mediated forms and pauci-immune ANCA-associated forms in which ANCA are thought to activate primed neutrophils against the vessel wall. The Chapel Hill nomenclature codifies these distinctions so that entities are named consistently rather than by eponym alone.

Clinical relevance

Recognising the vessel-size pattern and any ANCA association underpins how clinicians categorise a suspected vasculitis and interpret the literature on each subtype. This overview describes how the disorders are classified and studied; it characterises categories of disease and is not a basis for individual diagnosis or treatment decisions.

Epidemiology

The vasculitides are individually uncommon, and incidence varies by entity and geography: giant cell arteritis predominates in older adults of Northern European ancestry, Takayasu arteritis in younger women, and ANCA-associated vasculitis across middle and older age, with MPO-ANCA relatively more common in some Asian populations and PR3-ANCA in parts of Europe. Precise estimates depend on the classification criteria applied.

Evidence & guidelines

The 2012 Revised Chapel Hill Consensus Conference provides the reference nomenclature, and EULAR (with ACR collaboration) has issued management recommendations for large vessel vasculitis and for ANCA-associated vasculitis. These documents frame the categories the topic entries elaborate.

History

Vasculitis classification evolved from nineteenth- and twentieth-century eponymous descriptions toward systematic schemes. The 1994 Chapel Hill Consensus Conference introduced vessel-size-based definitions, and the 2012 revision updated the nomenclature, retired some eponyms, and incorporated the ANCA-associated category, giving the field a shared vocabulary.

Key figures

J. Charles Jennette
Ronald J. Falk
Bernhard Hellmich
Raashid Luqmani

Seminal works

jennette-2012
hellmich-2020
hellmich-2024

Frequently asked questions

How are the vasculitides classified?: Primarily by the calibre of the vessels predominantly affected — large, medium, and small — under the 2012 Revised Chapel Hill Consensus Conference nomenclature, with several small-vessel forms further defined by association with ANCA.
What does 'large vessel disease' mean in this area?: It refers chiefly to granulomatous arteritis of the aorta and its major branches, as in giant cell arteritis and Takayasu arteritis, where inflammation can cause stenosis, occlusion, or aneurysm of large arteries.